Article

Wills Eye Hospital promotes Dr. Kammi Gunton to chief of pediatric ophthalmology service

Expansion of program aims to provide more children with improved eye care; enhance the teaching of Wills residents and fellows

Wills Eye Hospital announces the promotion of Kammi B. Gunton, MD to chief of the pediatric ophthalmology service.

Gunton is a board-certified ophthalmologist who specializes in pediatric and adolescent ophthalmology and strabismus in adults. She previously served as the interim director of pediatric ophthalmology at Wills Eye and began her new role on March 11, 2022.

Wills Eye Hospital promotes Dr. Kammi Gunton to chief of pediatric ophthalmology service

Gunton

The service manages the care of eye diseases in children including such common challenges as misaligned eyes or poor visual development as well as complex cases with systemic associations. Pediatric ophthalmologists on the staff also engage in educational and research activities in addition to the clinical and surgical care of patients.

“We want to expand the reach of the Wills pediatric ophthalmology service so that we can provide pediatric eye care in community practices throughout the greater Philadelphia area,” Gunton said. “Expansion will not only provide more young Philadelphians with improved eye care but will enhance the teaching of Wills residents and fellows.”

Among many recent successes, Gunton has driven growth in clinical and research efforts, recruited new team members, and received grants to support the work of the service, said Julia A. Haller, MD, ophthalmologist-in-chief of Wills Eye Hospital.

Gunton has published numerous articles including a recent study on the impact of virtual schooling on children’s eyesight which received national attention.

Gunton is a graduate of Stanford University and received her medical degree from the University of California, San Francisco. She pursued her residency and fellowship training at Wills Eye and has been a pediatric ophthalmologist at the hospital since 2003.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Jason Bacharach, MD, on early-onset efficacy with perfluorohexyloctane in dry eye
(Image credit: Ophthalmology Times) CCOI's new CEO Malvina Eydelman, MD, outlines her mission and vision for the organization
(Image credit: Ophthalmology Times) ASCRS 2025: Deb Ristvedt, DO, on medications, lasers, and lifestyle in glaucoma management
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
(Image credit: Ophthalmology Times)  ASCRS 2025: Joaquin De Rojas, MD, leverages machine learning model to predict arcuate outcomes
© 2025 MJH Life Sciences

All rights reserved.